CleanAssure is laboratory developed, fingerstick blood test that provides objective data for medication reconciliation on a mass spectrometry platform. With a few drops of blood on the FDA approved microsampling device, you can take out the expensive and risky guesswork of reconciling medications with your patients.
Through scientific advances in Liquid Chromatography-Mass Spectrometry (LC-MS) testing, Cogent is now offering this patent-pending technology to empower Healthcare Providers across every transition of healthcare with empirical laboratory evidence of what their patient is taking, or not taking.
Cogent’s testing platform utilizes the latest in microsampling technology. The FDA Class 1 Mitra® microsampler device, makes specimen collection easy for the Patient and Clinician. No venipuncture blood draw or Phlebotomist is necessary to take the sample.
CleanAssure accurately tells you what medications are correctly reported, and what was missed or not reported during patient interviews from a few drops of blood.
Sample collection is minimally invasive, easy to administer and collect the specimen. No painful venipuncture stick or phlebotomist is required.
Cogent uses the FDA Class 1 Mitra device with VAMS™. Each collection absorbs 20ul of blood. This is the latest in Dried Blood Spot (DBS) sample collection.
Medication reconciliation is the process of identifying the most accurate list of all medications a patient is taking, and using this list to provide correct medications for patients anywhere within the healthcare system.
The goal is to avoid inadvertent inconsistencies across transitions in care by reviewing the patient’s complete medication regimen at the time of admission, transfer, and discharge and comparing it with the regimen being considered for the new setting of care.
When this process is done incorrectly or partially, Adverse Drug Events can happen.